UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTB
1551
DELISTED
Cooper Tire & Rubber Co.
CTB
| $2.85M | ﹤0.01% |
50,880
-4,464
| -8% | -$214K |
|
1552
WesBanco
WSBC
$4B
| $2.85M | ﹤0.01% |
78,935
-1,461
| -2% | -$48.1K |
|
|
AVYA
1553
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.83M | ﹤0.01% |
100,946
+1,334
| +1% | +$35.7K |
|
1554
First Bancorp
FBP
$4.38B
| $2.83M | ﹤0.01% |
251,033
-2,165
| -0.9% | -$22.7K |
|
1555
Prestige Consumer Healthcare
PBH
$2.6B
| $2.82M | ﹤0.01% |
64,019
-3,586
| -5% | -$151K |
|
1556
First Majestic Silver
AG
$9.07B
| $2.81M | ﹤0.01% |
180,240
+15,300
| +9% | +$245K |
|
1557
Sally Beauty Holdings
SBH
$1.58B
| $2.8M | ﹤0.01% |
139,249
+4,736
| +4% | +$79.3K |
|
1558
Clearway Energy Class C
CWEN
$6.7B
| $2.8M | ﹤0.01% |
99,491
+6,842
| +7% | +$210K |
|
1559
Federal Signal
FSS
$7.83B
| $2.8M | ﹤0.01% |
73,003
+489
| +0.7% | +$17.7K |
|
|
NAV
1560
DELISTED
Navistar International
NAV
| $2.77M | ﹤0.01% |
62,991
-8,690
| -12% | -$383K |
|
1561
APi Group
APG
$18B
| $2.77M | ﹤0.01% |
200,669
-9,786
| -5% | -$123K |
|
1562
3D Systems Corp
DDD
$613M
| $2.77M | ﹤0.01% |
100,812
-18,083
| -15% | -$598K |
|
1563
Hamilton Lane
HLNE
$5.57B
| $2.76M | ﹤0.01% |
31,192
+600
| +2% | +$50.7K |
|
1564
PROG Holdings
PRG
$1.71B
| $2.76M | ﹤0.01% |
63,707
-4,548
| -7% | -$227K |
|
|
SGTX
1565
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $2.76M | ﹤0.01% |
9,490
-125
| -1% | -$49.7K |
|
1566
Ligand Pharmaceuticals
LGND
$6.36B
| $2.74M | ﹤0.01% |
28,825
+882
| +3% | +$83.4K |
|
|
BLUE
1567
DELISTED
bluebird bio
BLUE
| $2.74M | ﹤0.01% |
7,019
-30,527
| -81% | -$15M |
|
|
TSE
1568
DELISTED
Trinseo
TSE
| $2.72M | ﹤0.01% |
42,774
-2,116
| -5% | -$129K |
|
1569
Plexus
PLXS
$7.23B
| $2.72M | ﹤0.01% |
29,576
-2,441
| -8% | -$207K |
|
|
DOOR
1570
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.71M | ﹤0.01% |
23,530
+1,469
| +7% | +$159K |
|
1571
GrafTech
EAF
$212M
| $2.71M | ﹤0.01% |
22,153
+10,033
| +83% | +$1.16M |
|
|
PRMW
1572
DELISTED
Primo Water Corporation
PRMW
| $2.71M | ﹤0.01% |
+166,487
| New | +$2.68M |
|
|
WBT
1573
DELISTED
Welbilt, Inc.
WBT
| $2.69M | ﹤0.01% |
165,818
-1,102
| -0.7% | -$16.6K |
|
1574
B&G Foods
BGS
$286M
| $2.69M | ﹤0.01% |
86,649
| – | – |
|
1575
WSFS Financial
WSFS
$4.15B
| $2.69M | ﹤0.01% |
54,028
-2,129
| -4% | -$103K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.